A significant shift in Canadian drug policy has occurred, as the authorities permit the use of psilocybin mushrooms for therapeutic treatment. Until now, these substances were heavily restricted, but a growing body of studies suggests they potentially offer benefits for psychological issues like PTSD. The new policy represents a major step toward r